Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S.
FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets. Position Overview The Director, Program Management is a hands-on program manager responsible for driving cross-functional planning and execution across two assets at different stages of development.
First, this role will serve as the program manager for our first ADC program as it transitions from early to late-stage development, building the integrated development plan, operating cadence, and governance infrastructure required to carry the asset forward. Second, this role will support an early-stage asset within our radiopharmaceutical portfolio, serving as both the program manager and the CMC project manager from candidate selection through IND-enabling activities and early clinical evaluation. This is a broad role that spans the development lifecycle and calls for a program manager who can drive stage-gate readiness for a maturing program while establishing the plans and processes that set an emerging one up for success.
Reporting to the Senior Vice President of Project and Program Management, the successful candidate will partner closely with Research, Nonclinical, CMC, Clinical Development, Clinical Operations, Regulatory Affairs, Quality, and external partners to translate program strategy into actionable plans, align teams to the critical path, and provide decision-ready reporting to governance forums and senior leadership.
This position will also contribute to evolving the program management operating model, tools, and templates to support a growing pipeline. Responsibilities ADC Program Management – Early to Late-Stage Transition Serve as the program manager for our first ADC asset, owning the integrated development plan across clinical, nonclinical, CMC, and regulatory workstreams. Drive the operational transition from early to late-stage development, evolving team structure, planning rigor, and governance cadence to meet late-stage requirements.
Build and maintain the integrated program timeline and critical path; proactively identify sequencing conflicts, resourcing constraints, and long-lead items. Drive preparation for key stage-gates, health authority interactions, and governance decision points, ensuring materials and recommendations are decision-ready. Radiopharmaceutical Program Management – Early Stage Serve as the program manager for an early-stage radiopharmaceutical asset, supporting the cross-functional team from candidate selection through IND-enabling activities and early clinical evaluation. Develop the integrated early development plan spanning discovery deliverables, nonclinical studies, CMC, regulatory strategy, and first-in-human readiness.
Coordinate workstreams into a single critical path and drive candidate selection and IND stage-gate readiness. Anticipate and plan for the operational and supply considerations specific to radiopharmaceutical development. CMC Project Management Represent CMC on the core product development team, serving as the point of accountability for CMC deliverables, timelines, and risks. Develop and drive integrated CMC